Benjamin Linas, MD
Associate Professor
Boston University School of Medicine
Dept of Medicine
Infectious Diseases

MD, New York University School of Medicine
MPH, Harvard School of Public Health




Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.

Associate Professor
Boston University School of Public Health
Epidemiology





Providence/Boston Center for AIDS Research(CFAR): Core B-Developmental
07/01/2018 - 06/30/2023 (PI)
Miriam Hospital NIH-NIAID

(Prenotification) Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term)
04/17/2019 - 03/31/2023 (PI)
University of Kentucky NIH-NIDA
1UM1DA049406-01

Researching Effective Strategies to Prevent Opioid Death(RESPOND)
06/01/2018 - 03/31/2023 (PI)
NIH-NIDA
5R01DA046527-02

Improving Naloxone Access and Its Effects on Drug Abuse Overdoses
03/04/2019 - 09/29/2021 (PI)
RAND Corporation CDC-NCIPC

A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs
09/01/2016 - 07/31/2021 (PI)
Trustees of Columbia University NIH-NIDA
5R01DA043130-04

BU Clinical HIV/AIDS Research Training Program
08/01/2016 - 07/31/2021 (PI)
NIH-NIAID
5T32AI052074-14

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment…
03/01/2018 - 12/31/2020 (PI)
Denver Health and Hospital Authority NIH-NIDA

A pragmatic trial of two strategies for implementing an effective eHealth HIV prevention program
09/01/2018 - 05/31/2020 (PI)
Northwestern University NIH-NIMH
1R01MH118213-01

Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health..
07/01/2015 - 04/30/2020 (PI)
Cornell University NIH-NIDA
5P30DA040500-05

Progression to and costs associated with opioid use disorder among adolescents and young adults
04/01/2019 - 03/31/2020 (PI)
NIH-NIDA
3R01DA046527-02S1

Showing 10 of 22 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs
2020 Researching Effective Strategies to Prevent Opioid Death (RESPOND) 5R01DA046527-03 3
2020 Researching Effective Strategies to Prevent Opioid Death (RESPOND) 5R01DA046527-03 3
2019 Researching Effective Strategies to Prevent Opioid Death (RESPOND) 5R01DA046527-02 3
2019 Researching Effective Strategies to Prevent Opioid Death (RESPOND) 3R01DA046527-02S1 3
2019 BU Clinical HIV/AIDS Research Training Program 5T32AI052074-14 51
2019 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-05-6229 121
2018 Researching Effective Strategies to Prevent Opioid Death (RESPOND) 1R01DA046527-01 3
2018 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-04-6229 121
2017 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-03-6229 121
2016 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-02-6229 121
Showing 10 of 21 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kimmel SD, Walley AY, Linas BP, Kalesan B, Awtry E, Dobrilovic N, White L, LaRochelle M. Effect of Publicly Reported Aortic Valve Surgery Outcomes on Valve Surgery in Injection Drug- and Non-Injection Drug-Associated Endocarditis. Clin Infect Dis. 2020 Jul 27; 71(3):480-487.View Related Profiles. PMID: 31598642
     
  2. Muyindike WR, Fatch R, Cheng DM, Emenyonu NI, Ngabirano C, Adong J, Linas BP, Jacobson KR, Hahn JA. Tuberculin skin test positivity among HIV-infected alcohol drinkers on antiretrovirals in south-western Uganda. PLoS One. 2020; 15(7):e0235261.View Related Profiles. PMID: 32614873
     
  3. Assoumou SA, Nolen S, Hagan L, Wang J, Eftekhari Yazdi G, Thompson WW, Mayer KH, Puro J, Zhu L, Salomon JA, Linas BP. Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study. Am J Med. 2020 Jun 27.View Related Profiles. PMID: 32603791
     
  4. Zhu L, Menzies NA, Wang J, Linas BP, Goodreau SM, Salomon JA. Estimation and correction of bias in network simulations based on respondent-driven sampling data. Sci Rep. 2020 Apr 14; 10(1):6348. PMID: 32286412
     
  5. Assoumou SA, Tasillo A, Vellozzi C, Eftekhari Yazdi G, Wang J, Nolen S, Hagan L, Thompson W, Randall LM, Strick L, Salomon JA, Linas BP. Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in US Prisons. Clin Infect Dis. 2020 Mar 17; 70(7):1388-1396.View Related Profiles. PMID: 31095676
     
  6. Gutkind S, Schackman BR, Morgan JR, Leff JA, Agyemang L, Murphy SM, Akiyama MJ, Norton BL, Litwin AH, Linas BP. Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs. Clin Infect Dis. 2020 Mar 17; 70(7):1397-1405.View Related Profiles. PMID: 31095683
     
  7. Assoumou SA, Wang J, Nolen S, Eftekhari Yazdi G, Mayer KH, Puro J, Salomon JA, Linas BP. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic. J Gen Intern Med. 2020 May; 35(5):1477-1483.View Related Profiles. PMID: 32133577
     
  8. Ghany MG, Morgan TR. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020 Feb; 71(2):686-721. PMID: 31816111
     
  9. Morgan JR, Wang J, Barocas JA, Jaeger JL, Durham NN, Babakhanlou-Chase H, Bharel M, Walley AY, Linas BP. Opioid overdose and inpatient care for substance use disorder care in Massachusetts. J Subst Abuse Treat. 2020 May; 112:42-48.View Related Profiles. PMID: 32199545
     
  10. Linas BP. Time for a New Approach to Guidance for HIV and HCV Testing Among Persons Who Inject Drugs. J Infect Dis. 2020 Jan 30. PMID: 32002538
     
Showing 10 of 95 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 95 publications over 18 distinct years, with a maximum of 22 publications in 2018

YearPublications
19961
19971
19981
20002
20062
20082
20093
20101
20112
20121
20132
20149
20155
20167
201711
201822
201912
202011
Contact for Mentoring:

771 Albany St
Boston MA 02118
Google Map


Linas's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department